cloperastine has been researched along with Benign Neoplasms in 2 studies
cloperastine: RN given refers to parent cpd
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, N | 1 |
| Ebihara, M | 1 |
| Oishi, S | 1 |
| Fujimoto, Y | 1 |
| Okada, T | 1 |
| Imamura, T | 1 |
| Urbina, F | 1 |
| Puhl, AC | 1 |
| Ekins, S | 1 |
1 review available for cloperastine and Benign Neoplasms
| Article | Year |
|---|---|
Recent advances in drug repurposing using machine learning.
Topics: Alzheimer Disease; Antineoplastic Agents; Antiviral Agents; Clemastine; Computational Biology; COVID | 2021 |
1 other study available for cloperastine and Benign Neoplasms
| Article | Year |
|---|---|
Histamine H1 receptor antagonists selectively kill cisplatin-resistant human cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Fibroblast Growth Factors; Gene E | 2021 |